Hong Kong

 

How insurers are delivering preventative care through tech

HBI speaks to Hong-Kong-based insure tech startup CareVoice about how its solution supports insurers to deliver more bespoke plans in China, following its $10m Series A. As most global insurers are trying to pivot from being gatekeepers to caregivers, can solutions that provide preventative support help?

All change at IHH as CEO departure announced

Pan-Asian hospital group IHH Healthcare has announced its CEO will change at the end of 2019, a refinancing of up to $250m of non-Lira debt and its Fortis deal boosted Q1 2019 results, while its Turkish subsidiary Acibadem is reportedly eyeing an investment in London.

Full year post-tax profits plummet at IHH

Pan-Asian hospital group IHH Healthcare saw 3% revenue growth, 9% EBITDA growth but a 35% plummet in post-tax profits in 2018. The results confirm its struggles in Turkey.

Quest Diagnostics changes strategy in emerging markets

Last week Healthcare Nova reported that US-based lab company Quest Diagnostics had sold its Indian medical diagnostics arm to Strand Life Sciences. We also reported that Quest has set up an international alliance of lab companies based in Brazil, Saudi Arabia, Korea, Hong Kong and Australia. Are the two moves connected? We speak to Quest's MD of global markets, Mark Machulcz to find out more about the group's change of strategy.

European domiciliary care provider breaks even in Asia

Buurtzorg, a Dutch domiciliary care business, is finally breaking even on the Asian market after a challenging first few years. We speak to Buurtzorg Asia's CEO Stephan Dyckerhoff about the difficulties of implementing his model in the far East.

Find Us